Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection

CompletedOBSERVATIONAL
Enrollment

1,965

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

January 16, 2024

Study Completion Date

January 16, 2024

Conditions
Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

ColonAiQ test and Colonoscopy

Diagnostic Test

Trial Locations (7)

200032

Fudan University Shanghai Cancer Center, Shanghai

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

250000

Cancer Hospital Affiliated to Shandong First Medical University (Shandong Institute of Cancer Prevention and Control, Shangdong Cancer Hospital), Jinan

310000

Zhejiang provincial people's hospital, Hangzhou

710000

Xi'an Daxing Hospital, Xi’an

Xi'an Gaoxin Hospital, Xi’an

030012

Shanxi Provincial People's Hospital, Taiyuan

All Listed Sponsors
lead

Singlera Genomics Inc.

INDUSTRY